+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Covid-19 Vaccination Market 2024-2028

  • PDF Icon

    Report

  • 173 Pages
  • September 2024
  • Region: Global
  • TechNavio
  • ID: 5504938
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The COVID-19 vaccination market is forecasted to grow by USD -54598.89 million during 2022-2027, accelerating at a CAGR of -29.3% during the forecast period. The report on the COVID-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of vaccination programs, emergence of new COVID-19 variants, and expanded COVID-19 vaccine eligibility.

The COVID-19 vaccination market is segmented as below:

By Type

  • mRNA
  • Others

By Distribution Channel

  • Government entities
  • Hospitals and clinics
  • Others

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • Rest of World (ROW)
This study identifies the rising R&D investment as one of the prime reasons driving the COVID-19 vaccination market growth during the next few years. Also, launch of new COVID-19 vaccines and adoption of technology and innovation in COVID-19 vaccination market will lead to sizable demand in the market.

The report on the COVID-19 vaccination market covers the following areas:

  • COVID-19 vaccination market sizing
  • COVID-19 vaccination market forecast
  • COVID-19 vaccination market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading COVID-19 vaccination market vendors that include AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd. Also, the COVID-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Additional Value/Volume Data
4.1 Global COVID-19 vaccination market 2021 - 2022 ($ million)
  • Market Size (value) - Data Table on Global COVID-19 vaccination market 2021 - 2022 ($ million)
4.2 Global COVID-19 vaccination market by Distribution Channel 2021 - 2022 ($ million)
  • Market Size (value) - Data Table on Global COVID-19 vaccination market by Distribution Channel 2021 - 2022 ($ million)
4.3 Global COVID-19 vaccination market by Type 2021 - 2022 ($ million)
  • Market Size (value) - Data Table on Global COVID-19 vaccination market by Type 2021 - 2022 ($ million)
4.4 Global COVID-19 vaccination market By Geographical Landscape 2021 - 2022 ($ million)
  • Market Size (value) - Data Table on Global COVID-19 vaccination market By Geographical Landscape 2021 - 2022 ($ million)
4.5 Global COVID-19 vaccination market by country 2021 - 2022 ($ million)
  • Market Size (value) - Data Table on Global COVID-19 vaccination market by Country 2021 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
6.3 Government entities - Market size and forecast 2023-2028
  • Chart on Government entities - Market size and forecast 2023-2028 ($ million)
  • Data Table on Government entities - Market size and forecast 2023-2028 ($ million)
  • Chart on Government entities - Year-over-year growth 2023-2028 (%)
  • Data Table on Government entities - Year-over-year growth 2023-2028 (%)
6.4 Hospitals and clinics - Market size and forecast 2023-2028
  • Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Type
7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
7.3 mRNA - Market size and forecast 2023-2028
  • Chart on mRNA - Market size and forecast 2023-2028 ($ million)
  • Data Table on mRNA - Market size and forecast 2023-2028 ($ million)
  • Chart on mRNA - Year-over-year growth 2023-2028 (%)
  • Data Table on mRNA - Year-over-year growth 2023-2028 (%)
7.4 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
  • Overview on factors of disruption
11.4 Industry risks
  • Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
  • Companies covered
12.2 Market positioning of companies
  • Matrix on companies position and classification
12.3 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
12.4 Bharat Biotech Ltd.
  • Bharat Biotech Ltd. - Overview
  • Bharat Biotech Ltd. - Product / Service
  • Bharat Biotech Ltd. - Key offerings
12.5 CureVac AG
  • CureVac AG - Overview
  • CureVac AG - Product / Service
  • CureVac AG - Key offerings
12.6 Emergent BioSolutions Inc.
  • Emergent BioSolutions Inc. - Overview
  • Emergent BioSolutions Inc. - Product / Service
  • Emergent BioSolutions Inc. - Key offerings
12.7 Genexine Inc.
  • Genexine Inc. - Overview
  • Genexine Inc. - Product / Service
  • Genexine Inc. - Key offerings
12.8 Inovio Pharmaceuticals Inc.
  • Inovio Pharmaceuticals Inc. - Overview
  • Inovio Pharmaceuticals Inc. - Product / Service
  • Inovio Pharmaceuticals Inc. - Key news
  • Inovio Pharmaceuticals Inc. - Key offerings
12.9 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
12.10 Moderna Inc.
  • Moderna Inc. - Overview
  • Moderna Inc. - Product / Service
  • Moderna Inc. - Key offerings
12.11 Novavax Inc.
  • Novavax Inc. - Overview
  • Novavax Inc. - Product / Service
  • Novavax Inc. - Key offerings
12.12 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
12.13 Serum Institute of India Pvt. Ltd.
  • Serum Institute of India Pvt. Ltd. - Overview
  • Serum Institute of India Pvt. Ltd. - Product / Service
  • Serum Institute of India Pvt. Ltd. - Key offerings
12.14 Shenzhen Kangtai Biological Products Co. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
  • Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
12.15 Sinovac Biotech Ltd.
  • Sinovac Biotech Ltd. - Overview
  • Sinovac Biotech Ltd. - Product / Service
  • Sinovac Biotech Ltd. - Key offerings
12.16 Tadbir innovation pharmaceutical Co.
  • Tadbir innovation pharmaceutical Co. - Overview
  • Tadbir innovation pharmaceutical Co. - Product / Service
  • Tadbir innovation pharmaceutical Co. - Key offerings
12.17 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
13.4 Research methodology
  • Research methodology
13.5 Data procurement
  • Information sources
13.6 Data validation
  • Data validation
13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
13.8 Data synthesis
  • Data synthesis
13.9 360 degree market analysis
  • 360 degree market analysis
13.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Market Size (value) - Data Table on Global COVID-19 vaccination market 2021 - 2022 ($ million)
Exhibits 21: Market Size (value) - Data Table on Global COVID-19 vaccination market by Distribution Channel 2021 - 2022 ($ million)
Exhibits 22: Market Size (value) - Data Table on Global COVID-19 vaccination market by Type 2021 - 2022 ($ million)
Exhibits 23: Market Size (value) - Data Table on Global COVID-19 vaccination market By Geographical Landscape 2021 - 2022 ($ million)
Exhibits 24: Market Size (value) - Data Table on Global COVID-19 vaccination market by Country 2021 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Distribution Channel
Exhibits 35: Data Table on Comparison by Distribution Channel
Exhibits 36: Chart on Government entities - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Government entities - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Government entities - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Government entities - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by Distribution Channel ($ million)
Exhibits 49: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 50: Chart on Type - Market share 2023-2028 (%)
Exhibits 51: Data Table on Type - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Type
Exhibits 53: Data Table on Comparison by Type
Exhibits 54: Chart on mRNA - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on mRNA - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on mRNA - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on mRNA - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 62: Market opportunity by Type ($ million)
Exhibits 63: Data Table on Market opportunity by Type ($ million)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 105: Market opportunity By Geographical Landscape ($ million)
Exhibits 106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 107: Impact of drivers and challenges in 2023 and 2028
Exhibits 108: Overview on criticality of inputs and factors of differentiation
Exhibits 109: Overview on factors of disruption
Exhibits 110: Impact of key risks on business
Exhibits 111: Companies covered
Exhibits 112: Matrix on companies position and classification
Exhibits 113: AstraZeneca Plc - Overview
Exhibits 114: AstraZeneca Plc - Product / Service
Exhibits 115: AstraZeneca Plc - Key news
Exhibits 116: AstraZeneca Plc - Key offerings
Exhibits 117: Bharat Biotech Ltd. - Overview
Exhibits 118: Bharat Biotech Ltd. - Product / Service
Exhibits 119: Bharat Biotech Ltd. - Key offerings
Exhibits 120: CureVac AG - Overview
Exhibits 121: CureVac AG - Product / Service
Exhibits 122: CureVac AG - Key offerings
Exhibits 123: Emergent BioSolutions Inc. - Overview
Exhibits 124: Emergent BioSolutions Inc. - Product / Service
Exhibits 125: Emergent BioSolutions Inc. - Key offerings
Exhibits 126: Genexine Inc. - Overview
Exhibits 127: Genexine Inc. - Product / Service
Exhibits 128: Genexine Inc. - Key offerings
Exhibits 129: Inovio Pharmaceuticals Inc. - Overview
Exhibits 130: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits 131: Inovio Pharmaceuticals Inc. - Key news
Exhibits 132: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits 133: Johnson and Johnson Services Inc. - Overview
Exhibits 134: Johnson and Johnson Services Inc. - Business segments
Exhibits 135: Johnson and Johnson Services Inc. - Key news
Exhibits 136: Johnson and Johnson Services Inc. - Key offerings
Exhibits 137: Johnson and Johnson Services Inc. - Segment focus
Exhibits 138: Moderna Inc. - Overview
Exhibits 139: Moderna Inc. - Product / Service
Exhibits 140: Moderna Inc. - Key offerings
Exhibits 141: Novavax Inc. - Overview
Exhibits 142: Novavax Inc. - Product / Service
Exhibits 143: Novavax Inc. - Key offerings
Exhibits 144: Pfizer Inc. - Overview
Exhibits 145: Pfizer Inc. - Product / Service
Exhibits 146: Pfizer Inc. - Key news
Exhibits 147: Pfizer Inc. - Key offerings
Exhibits 148: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 149: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits 150: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 151: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits 152: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibits 153: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits 154: Sinovac Biotech Ltd. - Overview
Exhibits 155: Sinovac Biotech Ltd. - Product / Service
Exhibits 156: Sinovac Biotech Ltd. - Key offerings
Exhibits 157: Tadbir innovation pharmaceutical Co. - Overview
Exhibits 158: Tadbir innovation pharmaceutical Co. - Product / Service
Exhibits 159: Tadbir innovation pharmaceutical Co. - Key offerings
Exhibits 160: Zydus Lifesciences Ltd. - Overview
Exhibits 161: Zydus Lifesciences Ltd. - Business segments
Exhibits 162: Zydus Lifesciences Ltd. - Key news
Exhibits 163: Zydus Lifesciences Ltd. - Key offerings
Exhibits 164: Zydus Lifesciences Ltd. - Segment focus
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Information sources
Exhibits 170: Data validation
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Data synthesis
Exhibits 173: 360 degree market analysis
Exhibits 174: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global COVID-19 vaccination market: AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising R&D investment."

According to the report, one of the major drivers for this market is the expansion of vaccination programs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AIVITA Biomedical Inc.
  • AnGes Inc.
  • AstraZeneca Plc
  • Bharat Biotech Ltd.
  • CureVac AG
  • Emergent BioSolutions Inc.
  • EuBiologics Co. Ltd.
  • Genexine Inc.
  • GreenLight Biosciences Holdings PBC
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Services Inc.
  • Moderna Inc.
  • Novavax Inc.
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Sinovac Biotech Ltd.
  • Tadbir innovation pharmaceutical Co.
  • The Gamaleya National Center of Epidemiology and Microbiology
  • Zydus Lifesciences Ltd.